Discover
VNDA
Vanda Pharmaceuticals Inc.
6.05
1 x 5.18
1 x 6.82
bid
ask
-
0.07
1.14%
1 @ 05:28 AM
6.05 +0.00 (0.00%)
| Ytd | -31.41% | |
| 1y | 29.27% |
5.96
day range
6.15
4.14
52 week range
9.94
| Open | 6.09 | Prev Close | 6.12 | Low | 5.96 | High | 6.15 | Mkt Cap | 363.82M |
| Vol | 743.28K | Avg Vol | 1.05M | EPS | -4.06 | P/E | N/A | Forward P/E | 23.40 |
| Beta | 0.77 | Short Ratio | 4.85 | Inst. Own | 78.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 6.35 | 200-d Avg | 6.45 | 1yr Est | 10.43 |
| Income Statement | |||
| Total Revenue | 51.72M | ||
| Revenues (USD) | 51.72M | ||
| Cost of Revenue | 3.16M | ||
| Gross Profit | 48.56M | ||
| Operating Expenses | 98.78M | ||
| Research and Development Expense | 28.44M | ||
| Selling, General and Administrative Expense | 68.36M | ||
| Operating Income | -50.22M | ||
| Income Tax Expense | 143.00K | ||
| Net Income | -48.57M | ||
| Net Income Common Stock | -48.57M | ||
| Net Income Common Stock (USD) | -48.57M | ||
| Consolidated Income | -48.57M | ||
| Earnings per Basic Share | -0.82 | ||
| Earnings per Basic Share (USD) | -0.82 | ||
| Earnings per Diluted Share | -0.82 | ||
| Earning Before Interest & Taxes (EBIT) | -48.42M | ||
| Earning Before Interest & Taxes (USD) | -48.42M | ||
| Weighted Average Shares | 59.46M | ||
| Weighted Average Shares Diluted | 59.46M | ||
| Balance Sheet | |||
| Cash and Equivalents | 54.03M | ||
| Cash and Equivalents (USD) | 54.03M | ||
| Investments | 148.28M | ||
| Investments Current | 148.28M | ||
| Trade and Non-Trade Receivables | 56.88M | ||
| Current Assets | 293.17M | ||
| Property, Plant & Equipment Net | 14.07M | ||
| Total Assets | 433.53M | ||
| Total Debt | 7.05M | ||
| Current Liabilities | 135.58M | ||
| Debt Non-Current | 7.05M | ||
| Total Liabilities | 152.76M | ||
| Accumulated Retained Earnings (Deficit) | -443.33M | ||
| Accumulated Other Comprehensive Income | 212.00K | ||
| Shareholders Equity | 280.77M | ||
| Shareholders Equity (USD) | 280.77M | ||
| Assets Non-Current | 140.36M | ||
| Total Debt (USD) | 7.05M | ||
| Goodwill and Intangible Assets | 115.10M | ||
| Inventory | 12.89M | ||
| Liabilities Non-Current | 17.18M | ||
| Trade and Non-Trade Payables | 60.62M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.53M | ||
| Net Cash Flow from Financing | -776.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -30.82M | ||
| Capital Expenditure | -10.22M | ||
| Issuance (Repayment) of Debt Securities | -776.00K | ||
| Net Cash Flow from Investing | 20.23M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 30.46M | ||
| Net Cash Flow from Operations | -50.22M | ||
| Effect of Exchange Rate Changes on Cash | -57.00K | ||
| Share Based Compensation | 2.56M | ||